Advertisement

U.S. markets open in 1 hour 41 minutes

S&P Futures
4,225.00
+15.25(+0.36%)
Dow Futures
33,414.00
+110.00(+0.33%)
Nasdaq Futures
13,363.25
+52.00(+0.39%)
Russell 2000 Futures
1,985.20
+8.90(+0.45%)
Crude Oil
92.85
-1.49(-1.58%)
Gold
1,801.20
-6.00(-0.33%)

Advertisement

Lyell Immunopharma, Inc. (LYEL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

7.19

-0.44

(-5.77%)

At close: 04:00PM EDT

6.92

-0.27

(-3.76%)

After hours:

04:42PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Short-term KST

View all chart patterns

Performance Outlook

Previous Close	7.63
Open	7.66
Bid	4.63 x 1200
Ask	12.00 x 800
Day's Range	7.14 - 7.68
52 Week Range	3.57 - 19.84
Volume	465,300
Avg. Volume	940,041

Market Cap	1.782B
Beta (5Y Monthly)	N/A
PE Ratio (TTM)	4.31
EPS (TTM)	1.67
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	14.67

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for LYEL

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Lyell Immunopharma, Inc.
Analyst Report: BioNTech SEBioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.
Rating
Fair Value
Economic Moat
3 days agoMorningstar